Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

Michele Bartoletti; Roberta Mazzeo; Marco De Scordilli; Anna Del Fabro; Maria Grazia Vitale; Lucia Bortot; Milena Sabrina Nicoloso; Serena Corsetti; Marta Bonotto; Simona Scalone; Giorgio Giorda; Roberto Sorio; Claudia Andreetta; Maria Luisa Meacci; Rocco De Vivo; Gianpiero Fasola; Francesco Sopracordevole; Fabio Puglisi

doi:10.1136/ijgc-2020-001771

Article info

other Versions

You are currently viewing an earlier version of this article (November 02, 2020).
View the most recent version of this article

Original research

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

Authors

Michele Bartoletti Department of Medicine, University of Udine, Udine, ItalyDepartment of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles
Roberta Mazzeo Department of Medicine, University of Udine, Udine, ItalyDepartment of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles
Marco De Scordilli Department of Medicine, University of Udine, Udine, ItalyDepartment of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles
Anna Del Fabro Unit of Gynecological Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Centro di Riferimento Oncologico, Aviano, Italy PubMed articles Google scholar articles
Maria Grazia Vitale Department of Medicine, University of Udine, Udine, ItalyDepartment of Oncology, ASUFC Udine University Hospital, Udine, Italy PubMed articles Google scholar articles
Lucia Bortot Department of Medicine, University of Udine, Udine, ItalyDepartment of Oncology, ASUFC Udine University Hospital, Udine, Italy PubMed articles Google scholar articles
Milena Sabrina Nicoloso Unit of Molecular Oncology, Centro di Riferimento Oncologico, Aviano, Italy PubMed articles Google scholar articles
Serena Corsetti Department of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles
Marta Bonotto Department of Oncology, ASUFC Udine University Hospital, Udine, Italy PubMed articles Google scholar articles
Simona Scalone Department of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles
Giorgio Giorda Unit of Gynecological Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Centro di Riferimento Oncologico, Aviano, Italy PubMed articles Google scholar articles
Roberto Sorio Department of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles
Claudia Andreetta Department of Oncology, ASUFC Udine University Hospital, Udine, Italy PubMed articles Google scholar articles
Maria Luisa Meacci Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy PubMed articles Google scholar articles
Rocco De Vivo Department of Oncology, Ospedale San Bortolo, Azienda ULSS8 Berica, Vicenza, Italy PubMed articles Google scholar articles
Gianpiero Fasola Department of Oncology, ASUFC Udine University Hospital, Udine, Italy PubMed articles Google scholar articles
Francesco Sopracordevole Unit of Gynecological Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Centro di Riferimento Oncologico, Aviano, Italy PubMed articles Google scholar articles
Fabio Puglisi Department of Medicine, University of Udine, Udine, ItalyDepartment of Medical Oncology, Unit of Medical Oncology & Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy PubMed articles Google scholar articles

Correspondence to Dr Michele Bartoletti, Department of Clinical Oncology and Prevention, Centro di Riferimento Oncologico, Aviano 33081, Italy; michele.bartoletti{at}cro.it

View Full Text

Citation

Bartoletti M, Mazzeo R, De Scordilli M, et al

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

International Journal of Gynecologic Cancer Published Online First: 30 September 2020. doi: 10.1136/ijgc-2020-001771

Publication history

Received June 19, 2020
Revision received September 1, 2020
Accepted September 3, 2020
First published September 30, 2020.

Article Versions

You are currently viewing a Previous version of this article (2 November 2020).
View the most recent version of this article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password